Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prolyl 3-hydroxylase OGFOD1 is a conserved, iron and 2-oxoglutarate-dependent enzyme that catalyzes the post-translational hydroxylation of Pro62 in the small ribosomal subunit protein S23 (RPS23/uS12). This modification regulates the accuracy and efficiency of translation termination, and impacts cellular proliferation, stress granule formation, and autophagy. OGFOD1 is part of the broad family of 2OG-dependent oxygenases, sharing structural similarity to hypoxia-inducible factor prolyl hydroxylases; its activity is sensitive to iron chelators and oxygenase inhibitors. Loss or inhibition of OGFOD1 results in decreased RPS23 hydroxylation, reduced translation, context-dependent growth arrest, and altered mRNA splicing, with implications for cancer, cardiac biology, and stress adaptation. OGFOD1's unique role in ribosome function distinguishes it among the oxygenase family, and it is considered a therapeutic and research target for modulation of translation and stress pathways.
Inhibition of OGFOD1 reduces prolyl hydroxylation of ribosomal protein RPS23, leading to translational arrest, reduced protein synthesis, stress granule formation, and downstream cellular stress responses. Inhibition can also lead to altered splicing patterns by reducing translation of specific splicing regulators
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prolyl 3-hydroxylase OGFOD1 (OGFOD1).